{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T21:03:01Z","timestamp":1790197381896,"version":"4.1.0"},"reference-count":68,"publisher":"Public Library of Science (PLoS)","issue":"10","license":[{"start":{"date-parts":[[2015,10,22]],"date-time":"2015-10-22T00:00:00Z","timestamp":1445472000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0140483","type":"journal-article","created":{"date-parts":[[2015,10,22]],"date-time":"2015-10-22T17:49:31Z","timestamp":1445536171000},"page":"e0140483","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":14,"title":["Application of the pMHC Array to Characterise Tumour Antigen Specific T Cell Populations in Leukaemia Patients at Disease Diagnosis"],"prefix":"10.1371","volume":"10","author":[{"given":"Suzanne E.","family":"Brooks","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephanie A.","family":"Bonney","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cindy","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amy","family":"Publicover","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ghazala","family":"Khan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Evelien L.","family":"Smits","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dagmar","family":"Sigurdardottir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew","family":"Arno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Demin","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ken I.","family":"Mills","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karen","family":"Pulford","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alison H.","family":"Banham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Viggo","family":"van Tendeloo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ghulam J.","family":"Mufti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hans-Georg","family":"Rammensee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tim J.","family":"Elliott","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kim H.","family":"Orchard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara-ann","family":"Guinn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2015,10,22]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1126\/science.1100369","article-title":"Cancer immunotherapy: a treatment for the masses","volume":"305","author":"JN Blattman","year":"2004","journal-title":"Science"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1002\/ijc.11292","article-title":"Antigen-specific immunotherapy and cancer vaccines","volume":"106","author":"E Jager","year":"2003","journal-title":"Int J Cancer"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1038\/nrc1669","article-title":"Cancer\/testis antigens, gametogenesis and cancer","volume":"5","author":"AJ Simpson","year":"2005","journal-title":"Nat Rev Cancer"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1126\/science.274.5284.94","article-title":"Phenotypic analysis of antigen-specific T lymphocytes","volume":"274","author":"JD Altman","year":"1996","journal-title":"Science"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1093\/protein\/10.8.975","article-title":"Mutagenesis of a flexible loop in streptavidin leads to higher affinity for the Strep-tag II peptide and improved performance in recombinant protein purification","volume":"10","author":"S Voss","year":"1997","journal-title":"Protein Eng"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"7568","DOI":"10.1073\/pnas.95.13.7568","article-title":"Direct visualization of antigen-specific T cells: HTLV-1 Tax11-19- specific CD8(+) T cells are activated in peripheral blood and accumulate in cerebrospinal fluid from HAM\/TSP patients","volume":"95","author":"TF Greten","year":"1998","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1038\/79573","article-title":"In situ detection of virus- and tumor-specific T-cell immunity","volume":"6","author":"JB Haanen","year":"2000","journal-title":"Nat Med"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1038\/nmeth.1345","article-title":"Parallel detection of antigen-specific T-cell responses by multidimensional encoding of MHC multimers","volume":"6","author":"SR Hadrup","year":"2009","journal-title":"Nat Methods"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"E65","DOI":"10.1371\/journal.pbio.0000065","article-title":"Detection and characterization of cellular immune responses using peptide-MHC microarrays","volume":"1","author":"Y Soen","year":"2003","journal-title":"PLoS Biol"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"e265","DOI":"10.1371\/journal.pmed.0020265","article-title":"Marked differences in human melanoma antigen-specific T cell responsiveness after vaccination using a functional microarray","volume":"2","author":"DS Chen","year":"2005","journal-title":"PLoS Med"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1038\/nmeth.1344","article-title":"Simultaneous detection of many T-cell specificities using combinatorial tetramer staining","volume":"6","author":"EW Newell","year":"2009","journal-title":"Nat Methods"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1038\/nbt.2593","article-title":"Combinatorial tetramer staining and mass cytometry analysis facilitate T-cell epitope mapping and characterization","volume":"31","author":"EW Newell","year":"2013","journal-title":"Nat Biotechnol"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.immuni.2012.01.002","article-title":"Cytometry by time-of-flight shows combinatorial cytokine expression and virus-specific cell niches within a continuum of CD8+ T cell phenotypes","volume":"36","author":"EW Newell","year":"2012","journal-title":"Immunity"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1007\/s00262-004-0640-7","article-title":"CD8+ T-cell response against MUC1-derived peptides in gastrointestinal cancer survivors","volume":"54","author":"J Dittmann","year":"2005","journal-title":"Cancer Immunol Immunother"},{"key":"ref15","first-page":"5818","article-title":"Integrated functional genomics approach for the design of patient-individual antitumor vaccines","volume":"62","author":"T Weinschenk","year":"2002","journal-title":"Cancer Res"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1006\/abio.1999.4363","article-title":"Protein microchips: use for immunoassay and enzymatic reactions","volume":"278","author":"P Arenkov","year":"2000","journal-title":"Anal Biochem"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1111\/j.1432-1033.1997.t01-1-00171.x","article-title":"Substrate specificity of cathepsins D and E determined by N-terminal and C-terminal sequencing of peptide pools","volume":"249","author":"D Arnold","year":"1997","journal-title":"Eur J Biochem"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"2100","DOI":"10.1182\/blood.V99.6.2100","article-title":"ALK as a novel lymphoma-associated tumor antigen: identification of 2 HLA-A2.1-restricted CD8+ T-cell epitopes","volume":"99","author":"L Passoni","year":"2002","journal-title":"Blood"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1007\/s00262-009-0774-8","article-title":"Direct discovery and validation of a peptide\/MHC epitope expressed in primary human breast cancer cells using a TCRm monoclonal antibody with profound antitumor properties","volume":"59","author":"B Verma","year":"2010","journal-title":"Cancer Immunol Immunother"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"7569","DOI":"10.1128\/JVI.70.11.7569-7579.1996","article-title":"The human cytotoxic T-lymphocyte (CTL) response to cytomegalovirus is dominated by structural protein pp65: frequency, specificity, and T-cell receptor usage of pp65-specific CTL","volume":"70","author":"MR Wills","year":"1996","journal-title":"J Virol"},{"key":"ref21","first-page":"4845","article-title":"Generation of survivin-specific CD8+ T effector cells by dendritic cells pulsed with protein or selected peptides","volume":"60","author":"M Schmitz","year":"2000","journal-title":"Cancer Res"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1038\/342443a0","article-title":"Anti-HLA-A2 antibody-enhancement of peptide association with HLA-A2 as detected by cytotoxic T lymphocytes","volume":"342","author":"H Bodmer","year":"1989","journal-title":"Nature"},{"key":"ref23","first-page":"5554","article-title":"The renal cell carcinoma-associated antigen G250 encodes a human leukocyte antigen (HLA)-A2.1-restricted epitope recognized by cytotoxic T lymphocytes","volume":"59","author":"JL Vissers","year":"1999","journal-title":"Cancer Res"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1084\/jem.183.2.527","article-title":"An HLA-A2-restricted tyrosinase antigen on melanoma cells results from posttranslational modification and suggests a novel pathway for processing of membrane proteins","volume":"183","author":"JC Skipper","year":"1996","journal-title":"J Exp Med"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1002\/(SICI)1097-0215(19990827)82:5<669::AID-IJC9>3.0.CO;2-#","article-title":"Mass-spectrometric evaluation of HLA-A*0201-associated peptides identifies dominant naturally processed forms of CTL epitopes from MART-1 and gp100","volume":"82","author":"JC Skipper","year":"1999","journal-title":"Int J Cancer"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"4659","DOI":"10.4049\/jimmunol.150.10.4659","article-title":"HLA A2 restricted cytotoxic T lymphocyte responses to multiple hepatitis B surface antigen epitopes during hepatitis B virus infection","volume":"150","author":"R Nayersina","year":"1993","journal-title":"J Immunol"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"1885","DOI":"10.1007\/s00262-007-0331-2","article-title":"HAGE, a cancer\/testis antigen with potential for melanoma immunotherapy: identification of several MHC class I\/II HAGE-derived immunogenic peptides","volume":"56","author":"MG Mathieu","year":"2007","journal-title":"Cancer Immunol Immunother"},{"key":"ref28","unstructured":"Smithgall M, Misher L, Spies G, Cheever MA, Gaiger A (2001) Identification of a novel WT1 HLA-A*0201-restricted CTL epitope using whole gene in vitro priming [abstract]. American Society of Hematology Meeting; December 8\u201311, 2001; Orlando, FL."},{"key":"ref29","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1172\/JCI118592","article-title":"Cytotoxic T lymphocyte responsiveness after resolution of chronic hepatitis B virus infection","volume":"97","author":"B Rehermann","year":"1996","journal-title":"J Clin Invest"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"2198","DOI":"10.1182\/blood.V95.7.2198","article-title":"Selective elimination of leukemic CD34(+) progenitor cells by cytotoxic T lymphocytes specific for WT1","volume":"95","author":"L Gao","year":"2000","journal-title":"Blood"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"3904","DOI":"10.4049\/jimmunol.152.8.3904","article-title":"Role of HLA-A motifs in identification of potential CTL epitopes in human papillomavirus type 16 E6 and E7 proteins","volume":"152","author":"WM Kast","year":"1994","journal-title":"J Immunol"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"1750","DOI":"10.4049\/jimmunol.160.4.1750","article-title":"Enhanced generation of specific tumor-reactive CTL in vitro by selected Melan-A\/MART-1 immunodominant peptide analogues","volume":"160","author":"D Valmori","year":"1998","journal-title":"J Immunol"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1002\/(SICI)1097-0215(20000201)85:3<391::AID-IJC16>3.0.CO;2-V","article-title":"Novel breast-tumor-associated MUC1-derived peptides: characterization in Db-\/- x beta2 microglobulin (beta2m) null mice transgenic for a chimeric HLA-A2.1\/Db-beta2 microglobulin single chain","volume":"85","author":"L Carmon","year":"2000","journal-title":"Int J Cancer"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"8078","DOI":"10.1073\/pnas.92.17.8078","article-title":"Induction of antigen-specific cytolytic T cells in situ in human melanoma by immunization with synthetic peptide-pulsed autologous antigen presenting cells","volume":"92","author":"B Mukherji","year":"1995","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1007\/s00262-010-0867-4","article-title":"Peptide microarrays for the profiling of cytotoxic T-lymphocyte activity using minimum numbers of cells","volume":"59","author":"A Hoff","year":"2010","journal-title":"Cancer Immunol Immunother"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"4309","DOI":"10.1182\/blood.V93.12.4309","article-title":"Identification of HLA-A2-restricted T-cell epitopes derived from the MUC1 tumor antigen for broadly applicable vaccine therapies","volume":"93","author":"P Brossart","year":"1999","journal-title":"Blood"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1006\/viro.1999.9996","article-title":"Frequency of CD8(+) T lymphocytes specific for lytic and latent antigens of Epstein-Barr virus in healthy virus carriers","volume":"264","author":"G Benninger-Doring","year":"1999","journal-title":"Virology"},{"key":"ref38","unstructured":"Rudolf D (2008) Efficient in vitro priming of tumor-and virus-specific CD8+ T cells with calibrated artifical APCs. PhD thesis, University of Tubingen."},{"key":"ref39","doi-asserted-by":"crossref","first-page":"2221","DOI":"10.1084\/jem.181.6.2221","article-title":"Class I major histocompatibility complex-restricted cytotoxic T lymphocytes specific for Epstein-Barr virus (EBV)-transformed B lymphoblastoid cell lines against which they were raised","volume":"181","author":"AB Hill","year":"1995","journal-title":"J Exp Med"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"2172","DOI":"10.1038\/sj.leu.2404424","article-title":"PASD1, a DLBCL-associated cancer testis antigen and candidate for lymphoma immunotherapy","volume":"20","author":"CD Cooper","year":"2006","journal-title":"Leukemia"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1093\/intimm\/8.6.927","article-title":"Solvent exposed side chains of peptides bound to HLA A*1101 have similar effects on the reactivity of alloantibodies and specific TCR","volume":"8","author":"QJ Zhang","year":"1996","journal-title":"Int Immunol"},{"key":"ref42","first-page":"16","article-title":"An analogue peptide from the Cancer\/Testis antigen PASD1 induces CD8+ T cell responses against naturally processed peptide","volume":"13","author":"N Hardwick","year":"2013","journal-title":"Cancer Immun"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"1638","DOI":"10.1002\/eji.1830250625","article-title":"Mapping and ranking of potential cytotoxic T epitopes in the p53 protein: effect of mutations and polymorphism on peptide binding to purified and refolded HLA molecules","volume":"25","author":"S Gnjatic","year":"1995","journal-title":"Eur J Immunol"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1084\/jem.185.9.1605","article-title":"Immediate early and early lytic cycle proteins are frequent targets of the Epstein-Barr virus-induced cytotoxic T cell response","volume":"185","author":"NM Steven","year":"1997","journal-title":"J Exp Med"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"2450","DOI":"10.1182\/blood.V88.7.2450.bloodjournal8872450","article-title":"Targeted T-cell therapy for human leukemia: cytotoxic T lymphocytes specific for a peptide derived from proteinase 3 preferentially lyse human myeloid leukemia cells","volume":"88","author":"J Molldrem","year":"1996","journal-title":"Blood"},{"key":"ref46","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1002\/ijc.2910460312","article-title":"Lymphokine-activated killer (LAK) cells discriminate between Epstein-Barr virus (EBV)-positive Burkitt&apos;s lymphoma cells","volume":"46","author":"IS Misko","year":"1990","journal-title":"Int J Cancer"},{"key":"ref47","doi-asserted-by":"crossref","first-page":"2876","DOI":"10.1002\/eji.200526207","article-title":"High frequencies of functionally impaired cytokeratin 18-specific CD8+ T cells in healthy HLA-A2+ donors","volume":"35","author":"S Walter","year":"2005","journal-title":"Eur J Immunol"},{"key":"ref48","doi-asserted-by":"crossref","first-page":"4342","DOI":"10.4049\/jimmunol.163.8.4342","article-title":"Specificity of CTL interactions with peptide-MHC class I tetrameric complexes is temperature dependent","volume":"163","author":"JA Whelan","year":"1999","journal-title":"J Immunol"},{"key":"ref49","unstructured":"Apperley J, Carreras E, Gluckman E, Masszi T. ESH-EBMT Handbook on Haemopoietic Stem Cell Transplantation. 2012 revised edition."},{"key":"ref50","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1111\/j.1365-2141.2009.07761.x","article-title":"Cytolytic T-cell response to the PASD1 cancer testis antigen in patients with diffuse large B-cell lymphoma","volume":"146","author":"K Ait-Tahar","year":"2009","journal-title":"Br J Haematol"},{"key":"ref51","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1084\/jem.180.1.347","article-title":"Identification of the immunodominant peptides of the MART-1 human melanoma antigen recognized by the majority of HLA-A2-restricted tumor infiltrating lymphocytes","volume":"180","author":"Y Kawakami","year":"1994","journal-title":"J Exp Med"},{"key":"ref52","doi-asserted-by":"crossref","first-page":"2366","DOI":"10.4049\/jimmunol.159.5.2366","article-title":"Cytolytic T lymphocyte recognition of the immunodominant HLA-A*0201-restricted Melan-A\/MART-1 antigenic peptide in melanoma","volume":"159","author":"P Romero","year":"1997","journal-title":"J Immunol"},{"key":"ref53","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1002\/jmr.805","article-title":"Detection of antigen-specific T cells on p\/MHC microarrays","volume":"20","author":"G Deviren","year":"2007","journal-title":"J Mol Recognit"},{"key":"ref54","doi-asserted-by":"crossref","first-page":"9695","DOI":"10.1021\/ja9006707","article-title":"Modular nucleic acid assembled p\/MHC microarrays for multiplexed sorting of antigen-specific T cells","volume":"131","author":"GA Kwong","year":"2009","journal-title":"J Am Chem Soc"},{"key":"ref55","doi-asserted-by":"crossref","first-page":"3825","DOI":"10.1073\/pnas.0709717105","article-title":"Conditional MHC class I ligands and peptide exchange technology for the human MHC gene products HLA-A1, -A3, -A11, and -B7","volume":"105","author":"AH Bakker","year":"2008","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref56","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.1038\/nprot.2006.121","article-title":"Generation of peptide-MHC class I complexes through UV-mediated ligand exchange","volume":"1","author":"B Rodenko","year":"2006","journal-title":"Nat Protoc"},{"key":"ref57","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1007\/978-1-59745-450-6_28","article-title":"High-throughput T-cell epitope discovery through MHC peptide exchange","volume":"524","author":"SR Hadrup","year":"2009","journal-title":"Methods Mol Biol"},{"key":"ref58","doi-asserted-by":"crossref","first-page":"12298","DOI":"10.1021\/ja9037559","article-title":"UV-induced ligand exchange in MHC class I protein crystals","volume":"131","author":"PH Celie","year":"2009","journal-title":"J Am Chem Soc"},{"key":"ref59","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1016\/j.bbrc.2005.08.024","article-title":"Humoral detection of leukaemia-associated antigens in presentation acute myeloid leukaemia","volume":"335","author":"BA Guinn","year":"2005","journal-title":"Biochem Biophys Res Commun"},{"key":"ref60","doi-asserted-by":"crossref","first-page":"3071","DOI":"10.1182\/blood.V84.9.3071.3071","article-title":"WT1 as a new prognostic factor and a new marker for the detection of minimal residual disease in acute leukemia","volume":"84","author":"K Inoue","year":"1994","journal-title":"Blood"},{"key":"ref61","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/S0167-5699(98)01299-7","article-title":"A very high level of crossreactivity is an essential feature of the T-cell receptor","volume":"19","author":"D Mason","year":"1998","journal-title":"Immunol Today"},{"key":"ref62","doi-asserted-by":"crossref","first-page":"5000","DOI":"10.4049\/jimmunol.151.9.5000","article-title":"Degenerate recognition of a dissimilar antigenic peptide by myelin basic protein-reactive T cells. Implications for thymic education and autoimmunity","volume":"151","author":"V Bhardwaj","year":"1993","journal-title":"J Immunol"},{"key":"ref63","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1182\/blood-2007-08-108241","article-title":"Leukemia-associated antigen-specific T-cell responses following combined PR1 and WT1 peptide vaccination in patients with myeloid malignancies","volume":"111","author":"K Rezvani","year":"2008","journal-title":"Blood"},{"key":"ref64","doi-asserted-by":"crossref","first-page":"350","DOI":"10.4049\/jimmunol.169.1.350","article-title":"Established human papillomavirus type 16-expressing tumors are effectively eradicated following vaccination with long peptides","volume":"169","author":"S Zwaveling","year":"2002","journal-title":"J Immunol"},{"key":"ref65","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1111\/bjh.12637","article-title":"Wilms&apos; Tumour 1 (WT1) peptide vaccination in patients with acute myeloid leukaemia induces short-lived WT1-specific immune responses","volume":"164","author":"B Uttenthal","year":"2014","journal-title":"Br J Haematol"},{"key":"ref66","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1182\/blood-2008-09-178848","article-title":"Elevated expression of the leukemia-associated antigen SSX2IP predicts survival in acute myeloid leukemia patients who lack detectable cytogenetic rearrangements","volume":"113","author":"B Guinn","year":"2009","journal-title":"Blood"},{"key":"ref67","doi-asserted-by":"crossref","first-page":"4109","DOI":"10.1182\/blood-2006-01-023127","article-title":"Expression of tumor-associated antigens in acute myeloid leukemia: Implications for specific immunotherapeutic approaches","volume":"108","author":"J Greiner","year":"2006","journal-title":"Blood"},{"key":"ref68","doi-asserted-by":"crossref","first-page":"e27254","DOI":"10.4161\/onci.27254","article-title":"The immune response in HPV oropharyngeal cancer","volume":"3","author":"EV King","year":"2014","journal-title":"Oncoimmunology"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0140483","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,11]],"date-time":"2024-06-11T22:59:55Z","timestamp":1718146795000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0140483"}},"subtitle":[],"editor":[{"given":"Nupur","family":"Gangopadhyay","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2015,10,22]]},"references-count":68,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2015,10,22]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0140483","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,10,22]]}}}